BDBM361999 US10221182, Compound E1-1.6::US10221182, Compound E2-1.6
SMILES: FC(F)c1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
InChI Key:
Data: 9 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glutamate receptor ionotropic, NMDA 2B (Homo sapiens (Human)) | BDBM361999 (US10221182, Compound E1-1.6 | US10221182, Compound...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 21.2 | n/a | n/a | n/a | n/a | n/a | n/a |
RUGEN HOLDINGS (CAYMAN) LIMITED US Patent | Assay Description HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met... | US Patent US10221182 (2019) BindingDB Entry DOI: 10.7270/Q2VQ34ZZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutamate receptor ionotropic, NMDA 2A (Homo sapiens (Human)) | BDBM361999 (US10221182, Compound E1-1.6 | US10221182, Compound...) | PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
RUGEN HOLDINGS (CAYMAN) LIMITED US Patent | Assay Description TBD | US Patent US10221182 (2019) BindingDB Entry DOI: 10.7270/Q2VQ34ZZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutamate receptor ionotropic, NMDA 2B (Homo sapiens (Human)) | BDBM361999 (US10221182, Compound E1-1.6 | US10221182, Compound...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
RUGEN HOLDINGS (CAYMAN) LIMITED US Patent | Assay Description HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met... | US Patent US10221182 (2019) BindingDB Entry DOI: 10.7270/Q2VQ34ZZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutamate receptor ionotropic, NMDA 2A (Homo sapiens (Human)) | BDBM361999 (US10221182, Compound E1-1.6 | US10221182, Compound...) | PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
RUGEN HOLDINGS (CAYMAN) LIMITED US Patent | Assay Description TBD | US Patent US10221182 (2019) BindingDB Entry DOI: 10.7270/Q2VQ34ZZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutamate receptor ionotropic, NMDA 2B (Homo sapiens (Human)) | BDBM361999 (US10221182, Compound E1-1.6 | US10221182, Compound...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
RUGEN HOLDINGS (CAYMAN) LIMITED US Patent | Assay Description HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met... | US Patent US10221182 (2019) BindingDB Entry DOI: 10.7270/Q2VQ34ZZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Potassium voltage-gated channel subfamily H member 2 (Homo sapiens (Human)) | BDBM361999 (US10221182, Compound E1-1.6 | US10221182, Compound...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
RUGEN HOLDINGS (CAYMAN) LIMITED US Patent | Assay Description The assay was performed on hERG channel stably expressed in HEK293 cells. The cells were cultured at 37° C. in a humidified CO2 incubator in the grow... | US Patent US10221182 (2019) BindingDB Entry DOI: 10.7270/Q2VQ34ZZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutamate receptor ionotropic, NMDA 2B (Homo sapiens (Human)) | BDBM361999 (US10221182, Compound E1-1.6 | US10221182, Compound...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
RUGEN HOLDINGS (CAYMAN) LIMITED US Patent | Assay Description HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met... | US Patent US10221182 (2019) BindingDB Entry DOI: 10.7270/Q2VQ34ZZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutamate receptor ionotropic, NMDA 2B (Homo sapiens (Human)) | BDBM361999 (US10221182, Compound E1-1.6 | US10221182, Compound...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 21.2 | n/a | n/a | n/a | n/a | n/a | n/a |
RUGEN HOLDINGS (CAYMAN) LIMITED US Patent | Assay Description HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met... | US Patent US10221182 (2019) BindingDB Entry DOI: 10.7270/Q2VQ34ZZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutamate receptor ionotropic, NMDA 2B (Homo sapiens (Human)) | BDBM361999 (US10221182, Compound E1-1.6 | US10221182, Compound...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 21.2 | n/a | n/a | n/a | n/a | n/a | n/a |
RUGEN HOLDINGS (CAYMAN) LIMITED US Patent | Assay Description HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met... | US Patent US10221182 (2019) BindingDB Entry DOI: 10.7270/Q2VQ34ZZ | |||||||||||
More data for this Ligand-Target Pair |